Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FZ0UU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,913
Award facts
- Contract value 100% obligated
- $13,913.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $13,913.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on September 10, 2025, with completion scheduled for September 11, 2025. This contract represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, utilizes the SPE2DX IDC as a flexible contracting mechanism to fulfill medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's federal contract portfolio demonstrates substantial capability in supporting defense health operations, with this Jardiance order representing a routine pharmaceutical delivery supporting military medical supply chains. The DLA Troop Support is concurrently developing the Pharmaceutical Prime Vendor Global Program Generation V contracts, which will involve multiple regional awards, positioning AmerisourceBergen among key strategic pharmaceutical vendors serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZ0UU?
SPE2DB25FZ0UU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FZ0UU worth?
The government has obligated $13,913 on SPE2DB25FZ0UU.
Is contract SPE2DB25FZ0UU an order under another contract?
Yes. SPE2DB25FZ0UU is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ0UU competed?
The extent of competition for SPE2DB25FZ0UU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award